Recurring iris pigment epithelial cyst induced by topical prostaglandin F2 alpha analogues.
Jørgen
J
Krohn
Vibeke K
VK
Hove
D000287:Administration, Topical; D000368:Aged; D000577:Amides / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D000069580:Bimatoprost; D003008:Cloprostenol / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D003560:Cysts / Q000139:chemically induced*; D015237:Dinoprost / Q000031:analogs & derivatives; D005260:Female; D005902:Glaucoma, Open-Angle / Q000188:drug therapy; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects; D007499:Iris Diseases / Q000139:chemically induced*; D000077338:Latanoprost; D010857:Pigment Epithelium of Eye; D011461:Prostaglandins F, Synthetic / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D012008:Recurrence; D019233:Retreatment
D000577:Amides; D011461:Prostaglandins F, Synthetic; D003008:Cloprostenol; D000077338:Latanoprost; D015237:Dinoprost; D000069580:Bimatoprost